High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats

References

• Ables, G.P., 2012. Update on Ppar. PPAR research, 2012, 1.
   Google Scholar
• Afrookhteh, A., et al., 2017. The circulating levels of complement-c1q/tnf-related protein 13 (ctrp13) in patients with type 2 diabetes and its association with insulin resistance. Clinical laboratory, 63 (02/2017), 327–333.
   PubMedGoogle Scholar
• Ahmed, M., 2015. Non-alcoholic fatty liver disease in 2015. World journal of hepatology, 7 (11), 1450–1459.
   PubMed Web of Science ®Google Scholar
• Akuta, N., et al., 2016. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan. Hepatology international, 10 (4), 647–656.
   PubMed Web of Science ®Google Scholar
• Alisi, A., et al.,, 2011. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Laboratory investigation, 91 (2), 283–293.
   PubMed Web of Science ®Google Scholar
• Aragno, M., et al.,, 2009. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free radical biology and Medicine, 47 (7), 1067–1074.
   PubMed Web of Science ®Google Scholar
• Arataki, K., et al., 2013. Circulating microRNA‐22 correlates with microRNA‐122 and represents viral replication and liver injury in patients with chronic hepatitis B. Journal of medical virology, 85 (5), 789–798.
   PubMed Web of Science ®Google Scholar
• Baselga-Escudero, L., et al.,, 2013. Chronic administration of proanthocyanidins or docosahexaenoic acid reverses the increase of miR-33a and miR-122 in dyslipidemic obese rats. PLoS One, 8 (7), e69817
   PubMed Web of Science ®Google Scholar
• Cassidy, S., et al.,, 2017. High-intensity interval training: a review of its impact on glucose control and cardiometabolic health. Diabetologia, 60 (1), 7–23.
   PubMed Web of Science ®Google Scholar
• Ceccarelli, S., et al.,, 2013. Dual role of microRNAs in NAFLD. International journal of molecular sciences, 14 (4), 8437–8455.
   PubMed Web of Science ®Google Scholar
• Cermelli, S., et al.,, 2011. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PloS One, 6 (8), e23937.
   PubMed Web of Science ®Google Scholar
• Chavanelle, V., et al.,, 2017. Effects of high-intensity interval training and moderate-intensity continuous training on glycaemic control and skeletal muscle mitochondrial function in db/db mice. Scientific reports, 7 (1), 204.
   PubMedGoogle Scholar
• Cheung, O., et al.,, 2008. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology, 48 (6), 1810–1820.
   PubMed Web of Science ®Google Scholar
• CHO, J., et al.,, 2014. Effect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL/6 mice. Journal of exercise nutrition and biochemistry, 18 (4), 339–346.
   PubMedGoogle Scholar
• Cui, S.F., et al., 2015. Acute responses of circulating microRNAs to low-volume sprint interval cycling. Frontiers in physiology, 6, 311.
   PubMed Web of Science ®Google Scholar
• De Oliveira Sá, G., et al., 2017. High-intensity interval training has beneficial effects on cardiac remodeling through local renin-angiotensin system modulation in mice fed high-fat or high-fructose diets. Life sciences, 189, 8–17.
   PubMed Web of Science ®Google Scholar
• Deightondeighton, K., et al.,, 2013. Appetite, gut hormone and energy intake responses to low volume sprint interval and traditional endurance exercise. European journal of applied physiology, 113 (5), 1147–1156.
   PubMed Web of Science ®Google Scholar
• Ebrahimi, M., et al., 2018. How high-fat diet and high-intensity interval training affect lipid metabolism in the liver and visceral adipose tissue of rats. Comparative exercise physiology, 14 (1), 55–62.
   Web of Science ®Google Scholar
• Esau, C., et al., 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism, 3 (2), 87–98.
   PubMed Web of Science ®Google Scholar
• Francois, M.E. and Little, J.P. 2015. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes spectrum: a publication of the american diabetes spectrum : a publication of the American diabetes association, 28 (1), 39–44.
   PubMedGoogle Scholar
• Gerhard, G.S., and Distefano, J.K. 2015. Micro RNAs in the development of non-alcoholic fatty liver disease. World Journal of Hepatology, 7 (2), 226–234.
   PubMed Web of Science ®Google Scholar
• Ghareghanighareghani, P., et al., 2017. Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet fed mice. Obesity Research & Clinical Practice, 12, 80–89.
   PubMed Web of Science ®Google Scholar
• Ghorban, K., et al., 2016. Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major. Hematology, 21, 113–120.
   PubMed Web of Science ®Google Scholar
• Gibala, M.J., et al., 2012. Physiological adaptations to low‐volume, high‐intensity interval training in health and disease. The journal of physiology, 590 (5), 1077–1084.
   PubMed Web of Science ®Google Scholar
• Gibala, M.J., et al., 2009. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1α in human skeletal muscle. Journal of applied physiology, 106 (3), 929–934.
   PubMed Web of Science ®Google Scholar
• Gorgani-Firuzjaee, S., et al.,, 2015. SH2 domain-containing inositol 5-phosphatase (SHIP2) regulates de-novo lipogenesis and secretion of apoB100 containing lipoproteins in HepG2 cells. Biochemical and biophysical research communications, 464 (4), 1028–1033.
   PubMed Web of Science ®Google Scholar
• Gorgani-Firuzjaee, S. and Meshkani, R., 2015. SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cells. Free radical biology and medicine, 89, 679–689.
   PubMed Web of Science ®Google Scholar
• Hallsworth, K., et al., 2015. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clinical science, 129 (12), 1097–1105.
   PubMed Web of Science ®Google Scholar
• Hottenrott, K., Ludyga, S., and Schulze, S. 2012. Effects of high intensity training and continuous endurance training on aerobic capacity and body composition in recreationally active runners. Journal of sports science & medicine, 11, 483–488.
   PubMed Web of Science ®Google Scholar
• Hsu, S.-H., et al., 2012. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. Journal of clinical investigation, 122 (8), 2871–2883.
   PubMed Web of Science ®Google Scholar
• Hu, J., et al.,, 2012. MiR-122 in hepatic function and liver diseases. Protein and cell, 3 (5), 364–371.
   PubMed Web of Science ®Google Scholar
• Iliopoulos, D., et al., 2010. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. Journal of lipid research, 51 (6), 1513–1523.
   PubMed Web of Science ®Google Scholar
• Inoue, M., et al., 2005. Increased expression of PPARγ in high fat diet-induced liver steatosis in mice. Biochemical and biophysical research communications, 336 (1), 215–222.
   PubMed Web of Science ®Google Scholar
• Jin, X., et al., 2009. MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease. Digestive and liver disease, 41 (4), 289–297.
   Web of Science ®Google Scholar
• Johnson, N. A., Keating, S. E., and George, J. 2012. Exercise and the liver: implications for therapy in fatty liver disorders. Seminars in liver disease, 32 (1), 65–79.
   Google Scholar
• Lim, L.P., et al., 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433 (7027), 769–773.
   PubMed Web of Science ®Google Scholar
• Locke, G.R., Pemberton, J.H., and Phillips, S.F., 2000. Gastroenterological association. Gastroenterology, 119 (6), 1761–1778.
   PubMedGoogle Scholar
• Mandard, S. and Kersten, S. 2006. Regulation of lipogenic genes in obesity. In: R. Brigelius-Flohé and H.-G. Joost, eds. Nutritional Genomics: impact on Health and Disease. Wiley-VCH. 208–219
   Google Scholar
• Marques, C., et al.,, 2010. Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Brazilian journal of medical and biological research, 43 (5), 467–475.
   PubMed Web of Science ®Google Scholar
• Marquez, R.T., et al., 2010. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Laboratory investigation, 90 (12), 1727–1736.
   PubMed Web of Science ®Google Scholar
• Miyaaki, H., et al., 2014. Significance of serum and hepatic microRNA‐122 levels in patients with non‐alcoholic fatty liver disease. Liver international, 34 (7), e302.
   PubMed Web of Science ®Google Scholar
• Morita, K., et al., 2011. Clinical significance and potential of hepatic microRNA‐122 expression in hepatitis C. Liver international, 31 (4), 474–484.
   PubMed Web of Science ®Google Scholar
• Motta, V.F., Aguila, M.B., and Mandarim-de-Lacerda, C.A. 2016 High-intensity interval training (swimming) significantly improves the adverse metabolism and comorbidities in diet-induced obese mice. The Journal of sports medicine and physical fitness, 56, 655–663.
   PubMed Web of Science ®Google Scholar
• Nalcakan, G.R. 2014. The effects of sprint interval vs. continuous endurance training on physiological and metabolic adaptations in young healthy adults. Journal of human kinetics, 44 (1), 97–109.
   PubMed Web of Science ®Google Scholar
• Panera, N., et al., 2014. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. World journal of gastroenterology, 20 (41), 15079–15086.
   PubMed Web of Science ®Google Scholar
• Pettinelli, P., et al., 2009. Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochimica Et Biophysica Acta (BBA)-molecular basis of disease, 1792 (11), 1080–1086.
   PubMed Web of Science ®Google Scholar
• Pettinelli, P., and Videla, L.A. 2011. Up-regulation of PPAR-γ mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. The journal of clinical endocrinology & metabolism, 96 (5), 1424–1430.
   PubMed Web of Science ®Google Scholar
• Pirola, C.J., et al., 2015. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut, 64 (5), 800–812.
   PubMed Web of Science ®Google Scholar
• Roozbayani, M., et al., 2016. Effect of Continues Training and High Intensity Interval Training on miR-29a and CTGF Gene Expression in Male Wistar Diabetic Rats’ Heart Tissue. Iranian journal of diabetes & obesity (IJDO), 8 (3), 142–150.
   Google Scholar
• Sampey, B.P., et al., 2011. Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high‐fat diet. Obesity, 19 (6), 1109–1117.
   PubMed Web of Science ®Google Scholar
• Shanaki, M., et al., 2016a. The circulating CTRP13 in type 2 diabetes and non-alcoholic fatty liver patients. PloS One, 11 (12), e0168082.
   PubMed Web of Science ®Google Scholar
• Shanaki, M., et al., 2016b. Effects of resveratrol on crosstalk between canonical Β-catenin/Wnt and FOXO pathways in coronary artery disease patients with metabolic syndrome: a case control study. Iranian journal of pharmaceutical research: IJPR, 15, 547–559.
   PubMed Web of Science ®Google Scholar
• Shanaki, M., et al., 2017. Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes. Diabetes & metabolic syndrome: clinical research & reviews, 11, S467–S472.
   PubMed Web of Science ®Google Scholar
• Shibata, C., et al., 2013. Inhibition of microRNA122 decreases SREBP1 expression by modulating suppressor of cytokine signaling 3 expression. Biochemical and biophysical research communications, 438 (1), 230–235.
   PubMed Web of Science ®Google Scholar
• Shimano, H., et al., 1997. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. Journal of clinical investigation, 99 (5), 846–854.
   PubMed Web of Science ®Google Scholar
• Shimomura, I., Bashmakov, Y., and Horton, J.D. 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. Journal of biological chemistry, 274 (42), 30028–30032.
   PubMed Web of Science ®Google Scholar
• Smith, B.W. and Adams, L.A. 2011. Non-alcoholic fatty liver disease. Critical reviews in clinical laboratory sciences, 48 (3), 97–113.
   PubMed Web of Science ®Google Scholar
• Su, Q., et al., 2018. Role of MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Advanced Drug Delivery Reviews.
   PubMed Web of Science ®Google Scholar
• Tjønna, A.E., et al., 2008. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation, 118 (4), 346–354.
   PubMed Web of Science ®Google Scholar
• Tsai, W.C., et al., 2009. MicroRNA‐122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology, 49 (5), 1571–1582.
   PubMed Web of Science ®Google Scholar
• Wang, H., et al., 2017. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model. BioMed research international, 2017, 2503847.
   PubMed Web of Science ®Google Scholar
• Xiao, J., et al., 2016. miR‐212 downregulation contributes to the protective effect of exercise against non‐alcoholic fatty liver via targeting FGF‐21. Journal of cellular and molecular medicine, 20 (2), 204–216.
   PubMed Web of Science ®Google Scholar
• Xu, J., et al., 2011. Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Molecular carcinogenesis, 50 (2), 136–142.
   PubMed Web of Science ®Google Scholar
• Yamada, H., et al., 2013. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clinica chimica acta, 424, 99–103.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2013. Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease. Diabetes research and clinical practice, 99 (3), 327–334.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.-L., et al., 2006. Aberrant hepatic expression of PPARγ2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. Journal of biological chemistry, 281 (49), 37603–37615.
   PubMed Web of Science ®Google Scholar